Clinical trial
Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With…
NCT00282425 · Richard Burt, MD, Other · Terminated
Key facts
| NCT number | NCT00282425 |
|---|---|
| Title | Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis |
| Official title | Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis |
| Lead sponsor | Richard Burt, MD, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Scleroderma |
| Intervention type | Biological |
| Interventions | Hematopoietic stem cell transplantation |
| Enrollment | 8 |
| Start date | May 1, 2005 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Jan 26, 2006 |
| Last update posted | Dec 18, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: